|
|
|
xiii | |
| Preface to the First Edition |
|
xxxi | |
| Preface to the Third Edition |
|
xxxiii | |
| Dedication |
|
xxxv | |
|
PART 1: FUNDAMENTAL PRINCIPLES OF THE IMMUNE RESPONSE |
|
|
|
The human immune response |
|
|
3 | (14) |
|
|
|
Organization of the immune system |
|
|
17 | (22) |
|
|
|
|
|
|
|
|
|
39 | (14) |
|
|
|
|
|
Antigen receptor genes, gene products, and co-receptors |
|
|
53 | (26) |
|
|
|
|
|
|
|
The major histocompatibility complex |
|
|
79 | (12) |
|
|
|
Antigens and antigen processing |
|
|
91 | (12) |
|
|
|
|
|
Antigen-presenting cells and antigen presentation |
|
|
103 | (10) |
|
|
|
|
|
B-cell development and differentiation |
|
|
113 | (14) |
|
|
|
|
|
|
|
|
|
127 | (12) |
|
|
|
|
|
Cytokines and cytokine receptors |
|
|
139 | (34) |
|
|
|
|
|
|
|
Chemokines and chemokine receptors |
|
|
173 | (24) |
|
|
|
Lymphocyte adhesion and trafficking |
|
|
197 | (14) |
|
|
|
|
|
T-cell activation and tolerance |
|
|
211 | (14) |
|
|
|
|
|
|
|
Programmed cell death in lymphocytes |
|
|
225 | (12) |
|
|
|
|
|
|
|
PART 2: HOST DEFENSE MECHANISMS AND INFLAMMATION |
|
|
|
|
|
237 | (12) |
|
|
|
|
|
249 | (10) |
|
|
|
|
|
Helper T-cell subsets and control of the inflammatory response |
|
|
259 | (12) |
|
|
|
|
|
Cytotoxic lymphocyte function and natural killer cells |
|
|
271 | (16) |
|
|
|
|
|
|
|
Host defenses at mucosal surfaces |
|
|
287 | (18) |
|
|
|
|
|
|
|
Complement and complement deficiencies |
|
|
305 | (22) |
|
|
|
|
|
|
|
327 | (18) |
|
|
|
|
|
Mast cells, basophils and mastocytosis |
|
|
345 | (16) |
|
|
|
|
|
|
|
|
|
Eosinophils and eosinophilia |
|
|
361 | (16) |
|
|
|
PART 3: INFECTION AND IMMUNITY |
|
|
|
Immune response to extracellular bacteria |
|
|
377 | (12) |
|
|
|
|
|
Immune responses to intracellular bacteria |
|
|
389 | (22) |
|
|
|
|
|
|
|
Immune responses to spirochetes |
|
|
411 | (10) |
|
|
|
|
|
|
|
Immune responses to viruses |
|
|
421 | (12) |
|
|
|
|
|
Immune responses to protozoans |
|
|
433 | (14) |
|
|
|
|
|
Immune responses to helminths |
|
|
447 | (16) |
|
|
|
|
|
PART 4: IMMUNOLOGIC DEFICIENCIES |
|
|
|
Evaluation of the immunodeficient patient |
|
|
463 | (14) |
|
|
|
|
|
Infections in the immunocompromised host |
|
|
477 | (16) |
|
|
|
|
|
Development of the fetal and neonatal immune system |
|
|
493 | (10) |
|
|
|
Aging and the immune system |
|
|
503 | (10) |
|
|
|
|
|
Beatrix Grubeck-Loebenstein |
|
|
Primary antibody deficiencies |
|
|
513 | (18) |
|
|
|
Primary T-cell immunodeficiencies |
|
|
531 | (22) |
|
|
|
|
|
Inherited disorders of IFN-γ-, IFN-α/β-, and NF-kB-mediated immunity |
|
|
553 | (8) |
|
|
|
|
|
HIV infection and acquired immunodeficiency syndrome |
|
|
561 | (24) |
|
|
|
|
|
|
|
|
|
Immunodeficiency due to congenital, metabolic, infectious, surgical, and environmental factors |
|
|
585 | (12) |
|
|
|
|
|
PART 5: ALLERGIC DISEASES |
|
|
|
|
|
597 | (10) |
|
|
|
Management of the asthmatic patient |
|
|
607 | (20) |
|
|
|
|
|
|
|
627 | (14) |
|
|
|
Urticaria, angiodema, and anaphylaxis |
|
|
641 | (16) |
|
|
|
|
|
Allergic reactions to stinging and biting insects |
|
|
657 | (10) |
|
|
|
|
|
|
|
Atopic and contact dermatitis |
|
|
667 | (14) |
|
|
|
|
|
681 | (10) |
|
|
|
Eosinophil-associated gastrointestinal disorders (EGID) |
|
|
691 | (10) |
|
|
|
|
|
Allergic disorders of the eye |
|
|
701 | (8) |
|
|
|
|
|
|
|
|
|
709 | (16) |
|
|
|
Occupational and environmental allergic disorders |
|
|
725 | (14) |
|
|
|
|
|
PART 6: SYSTEMIC IMMUNE DISEASES |
|
|
|
Mechanisms of autoimmunity |
|
|
739 | (10) |
|
|
|
Systemic lupus erythematosus |
|
|
749 | (18) |
|
|
|
|
|
|
|
|
|
767 | (22) |
|
|
|
Juvenile idiopathic arthritis |
|
|
789 | (14) |
|
|
|
|
|
|
|
803 | (10) |
|
|
|
|
|
813 | (12) |
|
|
|
|
|
Inflammatory muscle diseases |
|
|
825 | (12) |
|
|
|
|
|
|
|
837 | (22) |
|
|
|
Small- and medium-vessel primary vasculitis |
|
|
859 | (26) |
|
|
|
|
|
Large-vessel vasculitides |
|
|
885 | (4) |
|
|
|
|
|
Autoinflammatory fever syndromes |
|
|
889 | (20) |
|
Jeroen C.H. van der Hilst |
|
|
|
|
|
|
Antiphospholipid syndrome |
|
|
909 | (12) |
|
|
|
|
|
PART 7: ORGAN SPECIFIC INFLAMMATORY DISEASE |
|
|
|
Immunohematologic disorders |
|
|
921 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Bullous diseases of the skin and mucous membranes |
|
|
935 | (16) |
|
|
|
|
|
|
|
951 | (12) |
|
|
|
|
|
963 | (14) |
|
|
|
|
|
Autoimmune peripheral neuropathies |
|
|
977 | (18) |
|
|
|
Immunologic renal diseases |
|
|
995 | (18) |
|
|
|
|
|
|
|
Inflammation and atherothrombosis |
|
|
1013 | (10) |
|
|
|
Autoimmune thyroid diseases |
|
|
1023 | (12) |
|
|
|
|
|
Diabetes and related autoimmune diseases |
|
|
1035 | (18) |
|
|
|
Immunologic lung diseases |
|
|
1053 | (20) |
|
|
|
|
|
|
|
1073 | (12) |
|
|
|
Immunologic ocular disease |
|
|
1085 | (14) |
|
|
|
|
|
|
|
Immunologic disease of the gastrointesinal tract |
|
|
1099 | (16) |
|
|
|
|
|
Inflammatory hepatobiliary cirrhosis |
|
|
1115 | (16) |
|
|
|
|
|
|
|
PART 8: NEOPLASIA AND THE IMMUNE SYSTEM |
|
|
|
|
|
1131 | (20) |
|
|
|
|
|
|
|
Lymphomas including Hodgkin lymphoma |
|
|
1151 | (16) |
|
|
|
|
|
|
|
|
|
1167 | (14) |
|
|
|
|
|
Tumor immunology and immunotherapy |
|
|
1181 | (18) |
|
|
|
|
|
|
|
|
|
|
Concepts and challenges in transplantation: rejection, immunosuppression and tolerance |
|
|
1199 | (16) |
|
|
|
Challenges and potentials of xenotransplantation |
|
|
1215 | (8) |
|
|
|
|
|
Hematopoietic stem cell transplantation for malignant diseases |
|
|
1223 | (14) |
|
|
|
|
|
|
|
Stem cell transplantation and immune reconstitution in immunodeficiency |
|
|
1237 | (16) |
|
|
|
|
|
|
|
1253 | (12) |
|
|
|
|
|
PART 10: PREVENTION AND THERAPY OF IMMUNOLOGIC DISEASES |
|
|
|
Immunoglobulin therapy: replacement and immunomodulation |
|
|
1265 | (16) |
|
|
|
Gene transfer therapy of immunologic diseases |
|
|
1281 | (12) |
|
|
|
|
|
|
|
1293 | (14) |
|
|
|
|
|
|
|
Nonsteroidal anti-inflammatory drugs |
|
|
1307 | (10) |
|
|
|
|
|
|
|
1317 | (14) |
|
|
|
Vivian Hernandez-Trujillo |
|
|
|
|
|
|
Immunomodulating pharmaceuticals |
|
|
1331 | (10) |
|
|
|
|
|
|
|
Protein kinase antagonists as therapeutic agents for immunological and inflammatory disorders |
|
|
1341 | (12) |
|
|
|
|
|
|
|
|
|
1353 | (30) |
|
|
|
|
|
Immunotherapy of allergic disease |
|
|
1383 | (10) |
|
|
|
|
|
1393 | (12) |
|
|
|
|
|
|
|
|
|
Monoclonal antibodies and fusion proteins |
|
|
1405 | (14) |
|
|
|
|
|
PART 11: DIAGNOSTIC IMMUNOLOGY |
|
|
|
Assessment of proteins of the immune system |
|
|
1419 | (16) |
|
|
|
|
|
|
|
1435 | (12) |
|
|
|
|
|
Assessment of functional immune responses |
|
|
1447 | (14) |
|
|
|
|
|
Assessment of neutrophil function |
|
|
1461 | (10) |
|
|
|
Assessment of human allergic diseases |
|
|
1471 | (14) |
|
|
|
|
|
1485 | (42) |
|
|
|
|
|
|
Selected CD molecules and their characteristics |
|
|
1505 | (8) |
|
|
|
Laboratory reference values |
|
|
1513 | (4) |
|
|
|
|
|
1517 | (4) |
|
|
|
|
|
1521 | (6) |
|
|
| Index |
|
1527 | |
